{"version":"1.0","type":"link","title":"New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response.","author_name":"Mohan Lal B 외","author_url":"https://prs-insight.online/author/Mohan%20Lal%20B","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/83357","thumbnail_width":1200,"thumbnail_height":630}